Bone Biologics Corporation (BBLG) (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced a planned reverse stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results